GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » E10

Bausch Health (TSX:BHC) E10 : C$-3.81 (As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bausch Health's adjusted earnings per share data for the three months ended in Dec. 2024 was C$0.356. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$-3.81 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was -6.80% per year. During the past 5 years, the average E10 Growth Rate was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bausch Health was 37.40% per year. The lowest was -59.30% per year. And the median was -7.25% per year.

As of today (2025-03-18), Bausch Health's current stock price is C$10.05. Bausch Health's E10 for the quarter that ended in Dec. 2024 was C$-3.81. Bausch Health's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Bausch Health was 669.00. The lowest was 79.39. And the median was 349.69.


Bausch Health E10 Historical Data

The historical data trend for Bausch Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health E10 Chart

Bausch Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.61 -3.13 -3.36 -3.35 -3.81

Bausch Health Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.35 -3.39 -3.48 -3.61 -3.81

Competitive Comparison of Bausch Health's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bausch Health's Shiller PE Ratio falls into.



Bausch Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bausch Health's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.356/127.3637*127.3637
=0.356

Current CPI (Dec. 2024) = 127.3637.

Bausch Health Quarterly Data

per share eps CPI Adj_EPS
201503 0.353 99.789 0.451
201506 -0.185 100.500 -0.234
201509 0.186 100.421 0.236
201512 -1.344 99.947 -1.713
201603 -1.428 101.054 -1.800
201606 -1.135 102.002 -1.417
201609 -4.575 101.765 -5.726
201612 -1.961 101.449 -2.462
201703 2.396 102.634 2.973
201706 -0.146 103.029 -0.180
201709 4.531 103.345 5.584
201712 1.852 103.345 2.282
201803 -9.519 105.004 -11.546
201806 -3.268 105.557 -3.943
201809 -1.303 105.636 -1.571
201812 -1.321 105.399 -1.596
201903 -0.201 106.979 -0.239
201906 -0.651 107.690 -0.770
201909 -0.185 107.611 -0.219
201912 -5.662 107.769 -6.691
202003 -0.600 107.927 -0.708
202006 -1.247 108.401 -1.465
202009 0.265 108.164 0.312
202012 -0.551 108.559 -0.646
202103 -2.149 110.298 -2.482
202106 -2.029 111.720 -2.313
202109 0.659 112.905 0.743
202112 0.243 113.774 0.272
202203 -0.241 117.646 -0.261
202206 -0.512 120.806 -0.540
202209 1.467 120.648 1.549
202212 -1.535 120.964 -1.616
202303 -0.753 122.702 -0.782
202306 0.093 124.203 0.095
202309 -1.394 125.230 -1.418
202312 -0.148 125.072 -0.151
202403 -0.230 126.258 -0.232
202406 0.041 127.522 0.041
202409 -0.312 127.285 -0.312
202412 0.356 127.364 0.356

Add all the adjusted EPS together and divide 10 will get our e10.


Bausch Health  (TSX:BHC) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Bausch Health was 669.00. The lowest was 79.39. And the median was 349.69.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bausch Health E10 Related Terms

Thank you for viewing the detailed overview of Bausch Health's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Lynne Carson Senior Officer
Robert Allen Spurr Senior Officer
Joseph Gordon Senior Officer
Steven Daniel Miller Director
Andrew Charles Von Eschenbach Director
Richard Urbain De Schutter Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Osama Eldessouky Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Amy Wechsler Director
William Douglas Humphries Senior Officer
John Paulson Director
Thomas Ross Sr. Director
Christina Ackermann Senior Officer
Joseph Papa Director, Senior Officer
Paul Herendeen Senior Officer